Bosnia & Herzegovina

 

Inflow of nurses to top five European markets

This week, HBI looks at the annual inflow of nurses from abroad to the big five Western European markets - the United Kingdom, Germany, France, Italy, and Spain - using public data from OECD. Those looking for an outlier need look no further than the UK.

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.

Affidea sale – potential price and buyers

European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.

CEE – a land of opportunity?

With 125 million people - 80 million of whom live in the big four (Poland, Romania, Czechia and Hungary) - CEE is a large and diverse market. But is it a tempting one? HBI-365 members heard an expert panel in our CEE State of the Regions broadcast suggest that while COVID is creating huge problems across the world, it is also creating opportunities in Central and Eastern Europe.

FREE BLOG New HBI pipeline tool reveals long-held investments 

Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.

Joseph Priel dies

The most successful health care entrepreneur in central and eastern Europe has died aged just 65. What was this formidable man like and what does this mean for his many ventures?

Interview: Giuseppe Recchi, CEO, Affidea

Healthcare Europa speaks to Giuseppe Recchi, CEO of pan-European advanced diagnostic imaging specialist Affidea, to find out about the company’s foray into outpatient care, the state of AI, and plans for the future.

FREE BLOG HBI Awards 2018: Programme that minimises radiation doses for CT scans

CT scans, particularly in emergency settings, can generate high doses of radiation. Affidea has rolled out a programme across its 235 centres in 16 countries which prescribes levels for 72 different CT scans. This is based on its database of 75,000 examinations a month. This has led to Affidea creating 105 unified protocols to standardize operating procedures for CT scans. This program is key to Affidea’s strategy for winning international tenders.

Find Us